Constitutive	O
dephosphorylation	O
and	O
activation	O
of	O
a	O
member	O
of	O
the	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
,	O
NF-AT1	B-protein
,	O
in	O
Tax-expressing	B-cell_type
and	I-cell_type
type	I-cell_type
I	I-cell_type
human	I-cell_type
T-cell	I-cell_type
leukemia	I-cell_type
virus-infected	I-cell_type
human	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
tax	O
gene	O
product	O
of	O
the	O
type	O
I	O
human	O
T-cell	O
leukemia	O
virus	O
(	O
HTLV-I	O
)	O
transactivates	O
interleukin-2	B-DNA
(	I-DNA
IL-2	I-DNA
)	I-DNA
gene	I-DNA
through	O
activation	O
of	O
an	O
enhancer	O
termed	O
CD28	B-DNA
responsive	I-DNA
element	I-DNA
(	O
CD28RE	B-DNA
)	O
.	O

Tax	B-protein
activation	O
of	O
the	O
CD28RE	B-DNA
is	O
partially	O
mediated	O
by	O
a	O
member	O
of	O
the	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
,	O
NF-AT1	B-protein
.	O

We	O
have	O
previously	O
shown	O
that	O
NF-AT1	B-protein
is	O
constitutively	O
active	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
stably	O
transfected	O
with	O
the	O
Tax	B-DNA
cDNA	I-DNA
,	O
although	O
the	O
underlying	O
molecular	O
mechanism	O
and	O
physiological	O
relevance	O
of	O
this	O
finding	O
remain	O
unclear	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
the	O
active	O
form	O
of	O
NF-AT1	B-protein
is	O
also	O
present	O
in	O
the	O
nuclei	O
of	O
HTLV-I-transformed	B-cell_type
T	I-cell_type
cells	I-cell_type
that	O
express	O
the	O
Tax	B-protein
protein	I-protein
.	O

Interestingly	O
,	O
the	O
constitutive	O
activation	O
of	O
NF-AT1	B-protein
in	O
these	O
T	B-cell_type
cells	I-cell_type
is	O
associated	O
with	O
its	O
dephosphorylation	O
.	O

Furthermore	O
,	O
the	O
dephosphorylated	O
NF-AT1	B-protein
can	O
be	O
rapidly	O
rephosphorylated	O
when	O
the	O
cells	O
are	O
incubated	O
with	O
cyclosporin	O
A	O
,	O
an	O
immunosuppressant	O
inhibiting	O
the	O
serine/threonine	B-protein
phosphatase	I-protein
calcineurin	B-protein
.	O

These	O
results	O
suggest	O
that	O
activation	O
of	O
NF-AT1	B-protein
in	O
Tax-expressing	B-cell_line
and	I-cell_line
HTLV-I-transformed	I-cell_line
T	I-cell_line
cells	I-cell_line
results	O
from	O
its	O
dephosphorylation	O
,	O
which	O
in	O
turn	O
may	O
be	O
due	O
to	O
deregulation	O
of	O
calcineurin	B-protein

Communication	NULL
Constitutive	NULL
Dephosphorylation	NULL
and	NULL
Activation	NULL
of	NULL
a	NULL
Member	NULL
of	NULL
the	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
,	NULL
NF-AT1	NULL
,	NULL
in	NULL
Tax-expressing	NULL
and	NULL
Type	NULL
I	NULL
Human	NULL
T-cell	NULL
Leukemia	NULL
Virus-infected	NULL
Human	NULL
T	NULL
Cells*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
September	NULL
24	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
November	NULL
15	NULL
,	NULL
1996	NULL
)	NULL
LiFeng	NULL
Goodt	NULL
#	NULL
,	NULL
Sanjay	NULL
B.	NULL
Maggirwart	NULL
,	NULL
Edward	NULL
W.	NULL
Harhaj	NULL
,	NULL
and	NULL
Shao-Cong	NULL
Sun§	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Pennsylvania	NULL
State	NULL
University	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Hershey	NULL
Medical	NULL
Center	NULL
,	NULL
Hershey	NULL
,	NULL
Pennsylvania	NULL
17033	NULL
The	NULL
tax	NULL
gene	NULL
product	NULL
of	NULL
the	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
transactivates	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
through	NULL
activation	NULL
of	NULL
an	NULL
enhancer	NULL
termed	NULL
CD28	NULL
responsive	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
.	NULL

Tax	NULL
activation	NULL
of	NULL
the	NULL
CD28RE	NULL
is	NULL
partially	NULL
mediated	NULL
by	NULL
a	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
NF-AT1	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
NF-AT1	NULL
is	NULL
constitutively	NULL
active	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
Tax	NULL
cDNA	NULL
,	NULL
although	NULL
the	NULL
underlying	NULL
molecular	NULL
mechanism	NULL
and	NULL
physiological	NULL
relevance	NULL
of	NULL
this	NULL
finding	NULL
remain	NULL
unclear	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
active	NULL
form	NULL
of	NULL
NF-AT1	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
that	NULL
express	NULL
the	NULL
Tax	NULL
protein	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
these	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
its	NULL
dephosphorylation	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
dephosphorylated	NULL
NF-AT1	NULL
can	NULL
be	NULL
rapidly	NULL
rephosphorylated	NULL
when	NULL
the	NULL
cells	NULL
are	NULL
incubated	NULL
with	NULL
cyclosporin	NULL
A	NULL
,	NULL
an	NULL
immunosuppressant	NULL
inhibiting	NULL
the	NULL
serine/threonine	NULL
phosphatase	NULL
calcineurin	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
Tax-expressing	NULL
and	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
results	NULL
from	NULL
its	NULL
dephosphorylation	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
may	NULL
be	NULL
due	NULL
to	NULL
deregulation	NULL
of	NULL
calcineurin	NULL
.	NULL

The	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-1	NULL
)	NULL
'	NULL
is	NULL
an	NULL
etiologic	NULL
agent	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
,	NULL
an	NULL
aggressive	NULL
and	NULL
often	NULL
fatal	NULL
malignancy	NULL
of	NULL
mature	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
(	NULL
1-5	NULL
)	NULL
.	NULL

The	NULL
HTLV-I	NULL
genome	NULL
encodes	NULL
a	NULL
40-kDa	NULL
protein	NULL
,	NULL
termed	NULL
Tax	NULL
,	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
transcriptionally	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
various	NULL
cellular	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
T-cell	NULL
growth	NULL
factor	NULL
inter	NULL
*	NULL
This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
RO1	NULL
CA68471-01	NULL
and	NULL
an	NULL
AmFAR	NULL
grant	NULL
made	NULL
in	NULL
memory	NULL
of	NULL
Richard	NULL
Lee	NULL
Schiffman	NULL
(	NULL
to	NULL
S.-C.	NULL
S.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
The	NULL
first	NULL
two	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
717-531-4164	NULL
;	NULL
Fax	NULL
:	NULL
717-581-6522	NULL
;	NULL
E-mail	NULL
:	NULL
sxs70	NULL
@	NULL
psu.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
HTLV-I	NULL
,	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin-2	NULL
;	NULL
TCR	NULL
,	NULL
T-cell	NULL
receptor	NULL
;	NULL
CSA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoresis	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
CD28RE	NULL
,	NULL
CD28	NULL
responsive	NULL
element	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbc/	NULL
THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

3	NULL
,	NULL
Issue	NULL
of	NULL
January	NULL
17	NULL
,	NULL
pp	NULL
.	NULL

1425-1428	NULL
,	NULL
1997	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc	NULL
.	NULL

Printed	NULL
in	NULL
U.S.A.	NULL
leukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
the	NULL
«	NULL
subunit	NULL
of	NULL
its	NULL
high	NULL
affinity	NULL
receptor	NULL
complex	NULL
(	NULL
IL-2Ra	NULL
)	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
central	NULL
role	NULL
of	NULL
these	NULL
genes	NULL
in	NULL
normal	NULL
T-cell	NULL
activation	NULL
and	NULL
growth	NULL
suggests	NULL
that	NULL
this	NULL
specific	NULL
action	NULL
of	NULL
Tax	NULL
may	NULL
be	NULL
an	NULL
important	NULL
mechanism	NULL
underlying	NULL
HTLV-I-induced	NULL
T-cell	NULL
transformation	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Emerging	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
Tax	NULL
induces	NULL
the	NULL
target	NULL
genes	NULL
indirectly	NULL
by	NULL
modulating	NULL
the	NULL
activity	NULL
or	NULL
expression	NULL
of	NULL
specific	NULL
host	NULL
transcription	NULL
factors	NULL
(	NULL
6	NULL
,	NULL
8	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
Tax	NULL
induces	NULL
the	NULL
transcription	NULL
of	NULL
IL-2	NULL
gene	NULL
through	NULL
activation	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
an	NULL
IL-2	NULL
gene	NULL
enhancer	NULL
termed	NULL
CD28	NULL
responsive	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
(	NULL
9-12	NULL
)	NULL
.	NULL

At	NULL
least	NULL
two	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
NF-	NULL
«	NULL
B/Rel	NULL
and	NULL
NF-AT	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
CD28RE	NULL
enhancer	NULL
sequence	NULL
(	NULL
11-15	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Rel	NULL
factors	NULL
participate	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
a	NULL
large	NULL
array	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
growth	NULL
and	NULL
activation	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

This	NULL
family	NULL
contains	NULL
various	NULL
dimeric	NULL
complexes	NULL
composed	NULL
of	NULL
a	NULL
set	NULL
of	NULL
structurally	NULL
related	NULL
polypeptides	NULL
,	NULL
including	NULL
p50	NULL
(	NULL
NF-	NULL
«	NULL
B1	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
NF-	NULL
«	NULL
B2	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
previously	NULL
named	NULL
p65	NULL
)	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
the	NULL
proto-oncoprotein	NULL
c-Rel	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

19	NULL
)	NULL
.	NULL

The	NULL
biological	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
is	NULL
regulated	NULL
through	NULL
cytoplasmic	NULL
retention	NULL
by	NULL
association	NULL
with	NULL
specific	NULL
inhibitory	NULL
proteins	NULL
termed	NULL
IxBs	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Various	NULL
immunological	NULL
stimuli	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
,	NULL
induce	NULL
the	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
proteolysis	NULL
of	NULL
IxBs	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
active	NULL
forms	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
(	NULL
for	NULL
recent	NULL
re-views	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

21-28	NULL
)	NULL
.	NULL

NF-AT	NULL
represents	NULL
a	NULL
family	NULL
of	NULL
enhancer	NULL
binding	NULL
proteins	NULL
that	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
cytokine	NULL
genes	NULL
(	NULL
24-26	NULL
)	NULL
.	NULL

The	NULL
NF-AT	NULL
family	NULL
includes	NULL
at	NULL
least	NULL
four	NULL
structurally	NULL
related	NULL
proteins	NULL
,	NULL
NF-AT1	NULL
(	NULL
previously	NULL
named	NULL
NF-ATp	NULL
)	NULL
,	NULL
NF-ATc	NULL
,	NULL
NF-AT3	NULL
,	NULL
and	NULL
NF-AT4	NULL
(	NULL
27-31	NULL
)	NULL
.	NULL

In	NULL
normal	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
NF-AT	NULL
proteins	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
as	NULL
hyper-phosphorylated	NULL
inactive	NULL
precursors	NULL
(	NULL
27	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
stimuli	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
complex	NULL
or	NULL
the	NULL
calcium	NULL
ionophore	NULL
ionomycin	NULL
results	NULL
in	NULL
the	NULL
rapid	NULL
dephosphorylation	NULL
of	NULL
NF-AT	NULL
,	NULL
which	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
its	NULL
mobility	NULL
change	NULL
on	NULL
SDS-polyacrylamide	NULL
gels	NULL
(	NULL
82	NULL
,	NULL
34-86	NULL
)	NULL
.	NULL

Dephosphorylation	NULL
of	NULL
NF-AT	NULL
is	NULL
associated	NULL
with	NULL
its	NULL
nuclear	NULL
translocation	NULL
and	NULL
activation	NULL
of	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
34	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
serine/threonine	NULL
phosphatase	NULL
calcineurin	NULL
appears	NULL
to	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-AT	NULL
,	NULL
as	NULL
the	NULL
calcineurin	NULL
inhibitors	NULL
cyclosporin	NULL
A	NULL
(	NULL
CSA	NULL
)	NULL
and	NULL
FK506	NULL
block	NULL
the	NULL
signal-induced	NULL
dephosphorylation	NULL
and	NULL
the	NULL
subsequent	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-AT	NULL
(	NULL
34	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
further	NULL
support	NULL
of	NULL
this	NULL
notion	NULL
,	NULL
NF-AT	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
physically	NULL
associate	NULL
with	NULL
calcineurin	NULL
(	NULL
35	NULL
,	NULL
37	NULL
,	NULL
38	NULL
)	NULL
and	NULL
serve	NULL
as	NULL
a	NULL
substrate	NULL
of	NULL
calcineurin	NULL
in	NULL
vitro	NULL
(	NULL
39-41	NULL
)	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
NF-AT	NULL
regulation	NULL
may	NULL
differ	NULL
between	NULL
normal	NULL
T	NULL
cells	NULL
and	NULL
transformed	NULL
T-cell	NULL
lines	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
human	NULL
Jurkat	NULL
leukemic	NULL
T	NULL
cells	NULL
,	NULL
a	NULL
portion	NULL
of	NULL
NF-AT1	NULL
is	NULL
constitutively	NULL
localized	NULL
in	NULL
the	NULL
nucleus	NULL
even	NULL
when	NULL
the	NULL
cells	NULL
are	NULL
incubated	NULL
with	NULL
CSA	NULL
,	NULL
although	NULL
this	NULL
nuclear	NULL
form	NULL
of	NULL
NF-AT1	NULL
is	NULL
inactive	NULL
in	NULL
DNA	NULL
binding	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-AT1	NULL
is	NULL
constitutively	NULL
activated	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
eDNA	NULL
expression	NULL
vector	NULL
.	NULL

This	NULL
NF-AT	NULL
member	NULL
is	NULL
one	NULL
of	NULL
the	NULL
major	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
IL-2	NULL
CD28RE	NULL
and	NULL
appears	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
IL-2	NULL
promoter	NULL
in	NULL
these	NULL
Tax-expressing	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
1425	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
1426	NULL
that	NULL
NF-AT1	NULL
is	NULL
also	NULL
constitutively	NULL
activated	NULL
in	NULL
HTLV-I-infected	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
these	NULL
cells	NULL
results	NULL
from	NULL
its	NULL
dephosphorylation	NULL
through	NULL
a	NULL
CSA-sensitive	NULL
pathway	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture	NULL
and	NULL
Reagents-Human	NULL
Jurkat	NULL
leukemic	NULL
T	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

A	NULL
Jurkat	NULL
cell	NULL
line	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
Tax	NULL
cDNA	NULL
expression	NULL
vector	NULL
(	NULL
Jurkat-Tax	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

42	NULL
)	NULL
was	NULL
cultured	NULL
in	NULL
the	NULL
same	NULL
way	NULL
as	NULL
for	NULL
Jurkat	NULL
cells	NULL
except	NULL
that	NULL
the	NULL
medium	NULL
was	NULL
supplemented	NULL
with	NULL
400	NULL
ug/ml	NULL
G418	NULL
.	NULL

The	NULL
HTLV-I-infected	NULL
T-cell	NULL
lines	NULL
C8166	NULL
,	NULL
HUT1O2	NULL
,	NULL
K3T	NULL
,	NULL
MT-2	NULL
,	NULL
and	NULL
MT-4	NULL
cells	NULL
,	NULL
which	NULL
had	NULL
been	NULL
characterized	NULL
previously	NULL
(	NULL
48-46	NULL
)	NULL
,	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Except	NULL
for	NULL
MT-4	NULL
,	NULL
all	NULL
these	NULL
cells	NULL
express	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
HTLV-I	NULL
.	NULL

CSA	NULL
was	NULL
provided	NULL
by	NULL
Sandoz	NULL
Pharmaceuticals	NULL
Co.	NULL
(	NULL
East	NULL
Hanover	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

The	NULL
antibody	NULL
against	NULL
NF-AT1	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Anjana	NULL
Rao	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
;	NULL
see	NULL
Ref	NULL
.	NULL

27	NULL
)	NULL
.	NULL

The	NULL
antisera	NULL
specific	NULL
for	NULL
various	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

components	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Warner	NULL
C.	NULL
Greene	NULL
(	NULL
The	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Immunoblotting	NULL
and	NULL
Electrophoresis	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-The	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
and	NULL
noninfected	NULL
parental	NULL
Jurkat	NULL
or	NULL
Jurkat-Tax	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
at	NULL
800	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Subcel-lular	NULL
and	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
47	NULL
)	NULL
.	NULL

For	NULL
immunoblotting	NULL
analyses	NULL
,	NULL
protein	NULL
samples	NULL
(	NULL
~15	NULL
ug	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
7.5	NULL
%	NULL
reducing	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
and	NULL
then	NULL
analyzed	NULL
for	NULL
immunoreactivity	NULL
with	NULL
anti-NF-AT1	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
ECL	NULL
;	NULL
DuPont	NULL
NEN	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
by	NULL
incubating	NULL
the	NULL
nuclear	NULL
extracts	NULL
(	NULL
~5	NULL
ug	NULL
)	NULL
with	NULL
a	NULL
``	NULL
°P-radiolabeled	NULL
CD28RE	NULL
probe	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
(	NULL
AAA-GAAATTCCAAAGAGT	NULL
)	NULL
followed	NULL
by	NULL
resolving	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
on	NULL
native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
48	NULL
)	NULL
.	NULL

For	NULL
antibody	NULL
``	NULL
supershift	NULL
``	NULL
assays	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
diluted	NULL
antisera	NULL
(	NULL
5-fold	NULL
for	NULL
anti-NF-AT1	NULL
,	NULL
3-fold	NULL
for	NULL
the	NULL
various	NULL
anti-NF-	NULL
«	NULL
B	NULL
antisera	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
EMSA	NULL
reaction	NULL
5	NULL
min	NULL
before	NULL
electrophoresis	NULL
.	NULL

RESULTS	NULL
NF-AT1	NULL
Is	NULL
Constitutively	NULL
Active	NULL
in	NULL
HTLV-L-infected	NULL
Human	NULL
T	NULL
Cells-To	NULL
examine	NULL
whether	NULL
NF-AT1	NULL
is	NULL
active	NULL
in	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
°°P-labeled	NULL
human	NULL
IL-2	NULL
CD28RE	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
various	NULL
HTLV-I-infected	NULL
T-cell	NULL
lines	NULL
as	NULL
well	NULL
as	NULL
Jurkat	NULL
cells	NULL
or	NULL
Jurkat	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
fax	NULL
cDNA	NULL
(	NULL
Jurkat-Tax	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
(	NULL
11	NULL
)	NULL
,	NULL
two	NULL
major	NULL
protein	NULL
complexes	NULL
,	NULL
C1	NULL
and	NULL
C2	NULL
,	NULL
were	NULL
detected	NULL
from	NULL
the	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
while	NULL
only	NULL
low	NULL
amounts	NULL
of	NULL
the	NULL
C1	NULL
complex	NULL
were	NULL
found	NULL
from	NULL
the	NULL
parental	NULL
Jurkat	NULL
cells	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
C1	NULL
complex	NULL
varies	NULL
in	NULL
both	NULL
the	NULL
parental	NULL
Jurkat	NULL
cells	NULL
and	NULL
Jurkat-Tax	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
the	NULL
C2	NULL
complex	NULL
is	NULL
detectable	NULL
only	NULL
in	NULL
the	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
C2	NULL
complex	NULL
,	NULL
but	NULL
not	NULL
the	NULL
C1	NULL
complex	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
specifically	NULL
immunoreact	NULL
with	NULL
an	NULL
NF-AT1-specific	NULL
antibody	NULL
in	NULL
antibody	NULL
supershift	NULL
assays	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
NF-AT1	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
inducible	NULL
C2	NULL
complex	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
the	NULL
HTLV-l-infected	NULL
cell	NULL
lines	NULL
(	NULL
including	NULL
C8166	NULL
,	NULL
HUTI1O02	NULL
,	NULL
and	NULL
K3T	NULL
)	NULL
,	NULL
two	NULL
CD28RE-binding	NULL
complexes	NULL
were	NULL
detected	NULL
(	NULL
Zanes	NULL
3-5	NULL
,	NULL
C2	NULL
and	NULL
C3	NULL
)	NULL
,	NULL
one	NULL
of	NULL
which	NULL
(	NULL
C2	NULL
)	NULL
comigrated	NULL
with	NULL
the	NULL
NF-AT1	NULL
complex	NULL
from	NULL
the	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
,	NULL
C2	NULL
)	NULL
,	NULL
although	NULL
all	NULL
three	NULL
cell	NULL
lines	NULL
lacked	NULL
the	NULL
C1	NULL
complex	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
experiment	NULL
,	NULL
the	NULL
HTLV-I-infected	NULL
MT-2	NULL
cells	NULL
were	NULL
also	NULL
shown	NULL
to	NULL
express	NULL
the	NULL
C2	NULL
and	NULL
C3	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
another	NULL
HTLV-I-infected	NULL
cell	NULL
line	NULL
,	NULL
MT-4	NULL
,	NULL
that	NULL
was	NULL
deficient	NULL
in	NULL
Tax	NULL
expression	NULL
(	NULL
46	NULL
,	NULL
49	NULL
)	NULL
,	NULL
did	NULL
not	NULL
express	NULL
either	NULL
C2	NULL
or	NULL
C3	NULL
although	NULL
it	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
C1	NULL
complex	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
CD28RE-binding	NULL
complexes	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
C8166	NULL
cell	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
antibodies	NULL
for	NULL
various	NULL
known	NULL
IL-2	NULL
regulating	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
and	NULL
NF-AT1	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
antisera	NULL
against	NULL
the	NULL
p50	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
subunits	NULL
of	NULL
Activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
Cells	NULL
A	NULL
B	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
4	NULL
f	NULL
C1	NULL
-	NULL
#	NULL
»	NULL
-p	NULL
»	NULL
83—h-	NULL
n	NULL
``	NULL
CZ+	NULL
``	NULL
'	NULL
o-	NULL
``	NULL
WAW	NULL
C3	NULL
-t-NS	NULL
NOS	NULL
A	NULL
kee	NULL
3	NULL
toAp	NULL
,	NULL
NS	NULL
Tos	NULL
Ao	NULL
:	NULL
tay	NULL
Pz	NULL
¢	NULL
%	NULL
,5	NULL
``	NULL
o	NULL
,	NULL
Ny	NULL
\	NULL
@	NULL
\/	NULL
’	NULL
7	NULL
*	NULL
``	NULL
r	NULL
,	NULL
C	NULL
``	NULL
*y	NULL
C	NULL
*	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
*p	NULL
1	NULL
1	NULL
1	NULL
1	NULL
‘	NULL
L	NULL
‘	NULL
-as	NULL
--	NULL
UPD	NULL
NS	NULL
-	NULL
#	NULL
»	NULL
\	NULL
,	NULL
8	NULL
,	NULL
S	NULL
)	NULL
8	NULL
)	NULL
80	NULL
SOS	NULL
;	NULL
Ab	NULL
``	NULL
6	NULL
,	NULL
teng	NULL
ing	NULL
ng	NULL
ng	NULL
0g	NULL
tr	NULL
°	NULL
oy	NULL
oin	NULL
ff	NULL
$	NULL
0	NULL
2	NULL
(	NULL
°/	NULL
6:3	NULL
efé	NULL
‘	NULL
ds	NULL
%	NULL
.	NULL

¥	NULL
4	NULL
“	NULL
19	NULL
>	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
Jurkat-Tax	NULL
and	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
EMSA	NULL
analyses	NULL
of	NULL
CD28RE-binding	NULL
NF-AT1	NULL
complex	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
Jurkat	NULL
,	NULL
Jurkat-Tax	NULL
,	NULL
or	NULL
the	NULL
indicated	NULL
HTLV-I-transformed	NULL
T-cell	NULL
lines	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
a	NULL
*°P-labeled	NULL
CD28RE	NULL
probe	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
A	NULL
and	NULL
B	NULL
were	NULL
generated	NULL
from	NULL
two	NULL
different	NULL
experiments	NULL
,	NULL
in	NULL
which	NULL
the	NULL
gels	NULL
were	NULL
run	NULL
for	NULL
different	NULL
times	NULL
(	NULL
2	NULL
h	NULL
for	NULL
A	NULL
and	NULL
3	NULL
h	NULL
for	NULL
B	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
CD28RE-binding	NULL
proteins	NULL
were	NULL
designated	NULL
CI-C3	NULL
.	NULL

NS	NULL
indicates	NULL
a	NULL
non-specific	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
different	NULL
probes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
C2	NULL
complex	NULL
in	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
contain	NULL
NF-AT1	NULL
(	NULL
11	NULL
)	NULL
.	NULL

C	NULL
,	NULL
antibody	NULL
supershift	NULL
analysis	NULL
of	NULL
the	NULL
CD28RE-binding	NULL
proteins	NULL
in	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
nuclear	NULL
extract	NULL
isolated	NULL
from	NULL
C8166	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
EMSA	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
None	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
preimmune	NULL
or	NULL
immune	NULL
sera	NULL
.	NULL

The	NULL
supershifted	NULL
bands	NULL
are	NULL
indicated	NULL
with	NULL
arrowheads	NULL
.	NULL

NF-	NULL
«	NULL
B/Rel	NULL
selectively	NULL
supershifted	NULL
the	NULL
C3	NULL
complex	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
this	NULL
protein	NULL
complex	NULL
was	NULL
composed	NULL
of	NULL
both	NULL
p50	NULL
and	NULL
c-Rel	NULL
.	NULL

The	NULL
antisera	NULL
for	NULL
the	NULL
RelA	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
RelB	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
as	NULL
well	NULL
as	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
did	NULL
not	NULL
react	NULL
with	NULL
either	NULL
C2	NULL
or	NULL
C3	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
C2	NULL
complex	NULL
,	NULL
which	NULL
comigrated	NULL
with	NULL
the	NULL
NF-AT1	NULL
complex	NULL
in	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
C2	NULL
)	NULL
,	NULL
was	NULL
supershifted	NULL
by	NULL
the	NULL
anti-NF-AT1l	NULL
antiserum	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
using	NULL
the	NULL
nuclear	NULL
extracts	NULL
isolated	NULL
from	NULL
HUT1O2	NULL
,	NULL
K3T	NULL
,	NULL
and	NULL
MT2	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
antibody	NULL
supershift	NULL
assays	NULL
revealed	NULL
that	NULL
,	NULL
as	NULL
previously	NULL
observed	NULL
(	NULL
11	NULL
)	NULL
,	NULL
no	NULL
immunoreactivity	NULL
was	NULL
found	NULL
between	NULL
the	NULL
C1	NULL
complex	NULL
in	NULL
Jurkat	NULL
or	NULL
MT-4	NULL
and	NULL
the	NULL
anti-NF-AT1	NULL
antibody	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
NF-AT1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
Tax	NULL
protein	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
CD28RE	NULL
is	NULL
also	NULL
bound	NULL
by	NULL
the	NULL
p50/c-Rel	NULL
heterodimer	NULL
in	NULL
HTLV-L-infected	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
Jurkat-Tax	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
significantly	NULL
lower	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
activity	NULL
than	NULL
in	NULL
the	NULL
HTLV-I-infected	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
to	NULL
CD28RE	NULL
was	NULL
very	NULL
weak	NULL
.	NULL

However	NULL
,	NULL
the	NULL
p50/c-Rel	NULL
complex	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
especially	NULL
when	NULL
the	NULL
EMSA	NULL
conditions	NULL
were	NULL
modified	NULL
to	NULL
favor	NULL
the	NULL
binding	NULL
of	NULL
this	NULL
NF-	NULL
«	NULL
B/Rel	NULL
heterodimer	NULL
(	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
about	NULL
60	NULL
mm	NULL
NaCl	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
,	NULL
also	NULL
see	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

NF-AT1	NULL
Is	NULL
Constitutively	NULL
Dephosphorylated	NULL
in	NULL
Jurkat-Tax	NULL
and	NULL
HTLV	NULL
T	NULL
Cells-Activation	NULL
of	NULL
NF-AT1	NULL
by	NULL
immu-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
Cells	NULL
A	NULL
B	NULL
102030	NULL
4	NULL
10	NULL
%	NULL
3	NULL
4	NULL
t*	NULL
``	NULL
_	NULL
outh	NULL
tee	NULL
Wheel	NULL
quae	NULL
-a-	NULL
NF-	NULL
A	NULL
T	NULL
1	NULL
+-	NULL
x	NULL
Pini	NULL
set	NULL
i	NULL
Ni-	NULL
At	NULL
:	NULL
``	NULL
-+	NULL
Rll	NULL
Nie	NULL
Jurkat	NULL
Jurkat	NULL
7	NULL
}	NULL
tt	NULL
Ur	NULL
Tax	NULL
&	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

NF-AT1	NULL
is	NULL
constitutively	NULL
dephosphorylated	NULL
in	NULL
Tax-expressing	NULL
Jurkat	NULL
and	NULL
HTLV-I-infected	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
dephosphorylation	NULL
of	NULL
NF-AT1	NULL
occurs	NULL
in	NULL
Jurkat-Tax	NULL
but	NULL
not	NULL
the	NULL
parental	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
either	NULL
Jurkat	NULL
or	NULL
Jurkat-Tax	NULL
cells	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
using	NULL
an	NULL
NF-AT1-specific	NULL
antiserum	NULL
.	NULL

B	NULL
,	NULL
NF-AT1	NULL
is	NULL
dephosphorylated	NULL
in	NULL
Tax-expressing	NULL
but	NULL
not	NULL
Tax-deficient	NULL
HTLV-I-infected	NULL
cells	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
either	NULL
the	NULL
Tax-expressing	NULL
(	NULL
HUT102	NULL
,	NULL
K3T	NULL
,	NULL
and	NULL
MT-2	NULL
)	NULL
or	NULL
Tax-deficient	NULL
(	NULL
MT-4	NULL
)	NULL
HTLV-I-infected	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
NF-AT1	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
using	NULL
anti-NF-AT	NULL
antibody	NULL
.	NULL

The	NULL
molecular	NULL
sizes	NULL
for	NULL
NF-AT1	NULL
and	NULL
its	NULL
dephosphorylated	NULL
form	NULL
(	NULL
NF-AT1*	NULL
)	NULL
are	NULL
estimated	NULL
to	NULL
be	NULL
approximately	NULL
130	NULL
and	NULL
115	NULL
,	NULL
respectively	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

nological	NULL
stimuli	NULL
or	NULL
the	NULL
calcium	NULL
ionophore	NULL
ionomycin	NULL
involves	NULL
its	NULL
dephosphorylation	NULL
,	NULL
and	NULL
the	NULL
dephosphorylated	NULL
form	NULL
of	NULL
NF-ATI	NULL
migrates	NULL
more	NULL
rapidly	NULL
than	NULL
the	NULL
fully	NULL
phosphorylated	NULL
form	NULL
on	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
82	NULL
,	NULL
34	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
NF-AT1	NULL
also	NULL
resulted	NULL
from	NULL
dephosphorylation	NULL
of	NULL
NF-AT1	NULL
,	NULL
immunoblotting	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
analyze	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
NF-AT1	NULL
in	NULL
Jurkat-Tax	NULL
and	NULL
the	NULL
various	NULL
HTLV-I-infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
the	NULL
parental	NULL
Jurkat	NULL
cells	NULL
,	NULL
a	NULL
single	NULL
NF-AT1	NULL
protein	NULL
band	NULL
was	NULL
detected	NULL
,	NULL
and	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
83	NULL
)	NULL
,	NULL
this	NULL
phosphorylated	NULL
form	NULL
of	NULL
NF-AT1	NULL
was	NULL
located	NULL
in	NULL
both	NULL
cytoplasm	NULL
and	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
although	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
nuclear	NULL
NF-AT1	NULL
was	NULL
inactive	NULL
in	NULL
CD28RE	NULL
binding	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
Jurkat-Tax	NULL
cells	NULL
,	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
NF-AT1	NULL
was	NULL
present	NULL
in	NULL
its	NULL
more	NULL
rapidly	NULL
migrating	NULL
dephosphorylated	NULL
form	NULL
and	NULL
localized	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
NF-AT1*	NULL
)	NULL
.	NULL

The	NULL
dephosphorylated	NULL
form	NULL
of	NULL
NF-AT1	NULL
was	NULL
also	NULL
detected	NULL
from	NULL
the	NULL
Tax-expressing	NULL
HTLV-|-infected	NULL
HUT1O02	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
K3T	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
MT2	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
C8166	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
MT-4	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
deficient	NULL
in	NULL
Tax	NULL
expression	NULL
,	NULL
the	NULL
entire	NULL
NF-AT1	NULL
protein	NULL
pool	NULL
was	NULL
in	NULL
the	NULL
phosphorylated	NULL
form	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
4	NULL
,	NULL
NF-AT1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-AT1L	NULL
was	NULL
well	NULL
correlated	NULL
with	NULL
its	NULL
dephosphorylation	NULL
(	NULL
compare	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
NF-AT1	NULL
dephosphorylation	NULL
in	NULL
the	NULL
Tax-expressing	NULL
T	NULL
cells	NULL
appeared	NULL
to	NULL
vary	NULL
during	NULL
different	NULL
stages	NULL
of	NULL
cell	NULL
culture	NULL
,	NULL
with	NULL
fresh	NULL
culture	NULL
exhibiting	NULL
higher	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
significant	NULL
amount	NULL
of	NULL
the	NULL
fast	NULL
migrating	NULL
dephosphorylated	NULL
NF-AT1L	NULL
was	NULL
ever	NULL
detected	NULL
in	NULL
the	NULL
Tax-deficient	NULL
Jurkat	NULL
and	NULL
MT4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
it	NULL
suggests	NULL
that	NULL
activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
Tax-expressing	NULL
and	NULL
T	NULL
cells	NULL
likely	NULL
results	NULL
from	NULL
its	NULL
dephosphorylation	NULL
.	NULL

NF-AT1	NULL
Is	NULL
Rapidly	NULL
Rephosphorylated	NULL
and	NULL
Inactivated	NULL
in	NULL
Cells	NULL
Treated	NULL
with	NULL
CSA-To	NULL
explore	NULL
the	NULL
mechanism	NULL
of	NULL
NF-AT1L	NULL
dephosphorylation	NULL
and	NULL
to	NULL
further	NULL
correlate	NULL
the	NULL
dephosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
CSA	NULL
on	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-AT1	NULL
was	NULL
analyzed	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
the	NULL
HTLV-T-infected	NULL
K3T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
or	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
CSA	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoblot	NULL
to	NULL
analyze	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
different	NULL
forms	NULL
of	NULL
NF-AT1	NULL
in	NULL
both	NULL
cytoplasm	NULL
and	NULL
nucleus	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
CSA	NULL
treatment	NULL
for	NULL
as	NULL
short	NULL
as	NULL
5	NULL
min	NULL
led	NULL
to	NULL
the	NULL
disappearance	NULL
of	NULL
the	NULL
dephosphorylated	NULL
form	NULL
of	NULL
NF-AT1	NULL
,	NULL
which	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
increase	NULL
of	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
NF-AT1	NULL
in	NULL
both	NULL
cytoplasm	NULL
and	NULL
nucleus	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
that	NULL
seen	NULL
1427	NULL
A	NULL
B	NULL
1	NULL
2	NULL
%	NULL
3	NULL
4	NULL
t	NULL
:	NULL
gausk	NULL
®	NULL
``	NULL
Rag	NULL
tt	NULL
geet	NULL
<	NULL
4-	NULL
NF-	NULL
AT	NULL
-D	NULL
0	NULL
«	NULL
<	NULL
-NF-AT'-A	NULL
»	NULL
AL	NULL
s	NULL
,	NULL
SS	NULL
\	NULL
\o\	NULL
\	NULL
e	NULL
»	NULL
.	NULL
'	NULL

e	NULL
%	NULL
.	NULL
'	NULL

c	NULL
%	NULL
t	NULL
*	NULL
.	NULL

c	NULL
4	NULL
c	NULL
4	NULL
0	NULL
5	NULL
10	NULL
30	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
10	NULL
C	NULL
?	NULL

?	NULL

?	NULL

C1	NULL
»	NULL
NF-ATi-i	NULL
»	NULL
NF-xB/Rel-	NULL
»	NULL
NS-m	NULL
~	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
\o	NULL
\0	NULL
a	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
CSA	NULL
on	NULL
the	NULL
dephosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-AT1	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
immunoblotting	NULL
analysis	NULL
of	NULL
NF-AT1	NULL
in	NULL
K8T	NULL
(	NULL
A	NULL
)	NULL
or	NULL
Jurkat-Tax	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
CSA	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

Both	NULL
cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
extracts	NULL
were	NULL
analyzed	NULL
.	NULL

The	NULL
phosphorylated	NULL
(	NULL
NF-AT1	NULL
)	NULL
and	NULL
dephosphorylated	NULL
(	NULL
NF-AT1*	NULL
)	NULL
forms	NULL
of	NULL
NF-AT1L	NULL
are	NULL
indicated	NULL
.	NULL

C	NULL
,	NULL
EMSA	NULL
analysis	NULL
of	NULL
CD28RE-binding	NULL
proteins	NULL
in	NULL
Jurkat	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
Jurkat-Tax	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
cells	NULL
treated	NULL
with	NULL
CSA	NULL
(	NULL
1	NULL
pg/m1	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

The	NULL
NF-AT1	NULL
and	NULL
NF-kB/Re	NULL
!	NULL

l	NULL
complexes	NULL
are	NULL
indicated	NULL
.	NULL

with	NULL
immunologically	NULL
stimulated	NULL
murine	NULL
T	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
,	NULL
the	NULL
rephosphorylated	NULL
NF-AT1	NULL
in	NULL
these	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
relocate	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
even	NULL
after	NULL
30	NULL
min	NULL
of	NULL
CSA	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
3-8	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
parallel	NULL
EMSA	NULL
revealed	NULL
that	NULL
the	NULL
rephosphorylation	NULL
of	NULL
NF-AT1I	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
loss	NULL
of	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
both	NULL
the	NULL
Jurkat-Tax	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
and	NULL
K3T	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
cells	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
constitutive	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-AT1	NULL
in	NULL
Tax-expressing	NULL
and	NULL
HTLV-I-infected	NULL
T	NULL
cells	NULL
apparently	NULL
results	NULL
from	NULL
its	NULL
dephosphorylation	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
is	NULL
likely	NULL
mediated	NULL
by	NULL
the	NULL
CSA-sensitive	NULL
phosphatase	NULL
calcineurin	NULL
.	NULL

These	NULL
studies	NULL
also	NULL
indicate	NULL
that	NULL
the	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-AT1L	NULL
may	NULL
be	NULL
differentially	NULL
regulated	NULL
in	NULL
these	NULL
Tax-expressing	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
requires	NULL
both	NULL
the	NULL
TCR-mediated	NULL
primary	NULL
and	NULL
the	NULL
CD28-medi-ated	NULL
costimulatory	NULL
signals	NULL
.	NULL

However	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
infected	NULL
with	NULL
HTLV-I	NULL
or	NULL
expressing	NULL
the	NULL
viral	NULL
Tax	NULL
protein	NULL
,	NULL
various	NULL
pharma-cological	NULL
stimuli	NULL
that	NULL
mimic	NULL
the	NULL
TCR	NULL
signaling	NULL
are	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
12	NULL
,	NULL
42	NULL
)	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
Tax	NULL
may	NULL
provide	NULL
a	NULL
costimulatory	NULL
signal	NULL
for	NULL
T-cell	NULL
activation	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
Tax-responsive	NULL
element	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
has	NULL
been	NULL
identified	NULL
to	NULL
be	NULL
the	NULL
CD28RE	NULL
(	NULL
9-12	NULL
,	NULL
51	NULL
)	NULL
,	NULL
an	NULL
enhancer	NULL
element	NULL
known	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
CD28	NULL
costimulatory	NULL
signal	NULL
(	NULL
13	NULL
,	NULL
52	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
CD28RE	NULL
remain	NULL
unclear	NULL
.	NULL

Although	NULL
NF-	NULL
«	NULL
B/Rel	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
CD28RE	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
enhancer	NULL
(	NULL
12	NULL
)	NULL
,	NULL
additional	NULL
factors	NULL
are	NULL
clearly	NULL
required	NULL
since	NULL
a	NULL
Tax	NULL
mutant	NULL
(	NULL
M47	NULL
)	NULL
that	NULL
is	NULL
capable	NULL
of	NULL
NF-kB	NULL
activation	NULL
(	NULL
53	NULL
)	NULL
fails	NULL
to	NULL
transac-tivate	NULL
the	NULL
CD28RE	NULL
(	NULL
10	NULL
,	NULL
18	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
NF-AT1	NULL
binds	NULL
to	NULL
the	NULL
CD28RE	NULL
in	NULL
a	NULL
Tax-expressing	NULL
Jurkat	NULL
cell	NULL
line	NULL
(	NULL
Jurkat-Tax	NULL
)	NULL
and	NULL
participates	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
CD28RE	NULL
in	NULL
a	NULL
reporter	NULL
gene	NULL
assay	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-AT1	NULL
is	NULL
constitutively	NULL
activated	NULL
in	NULL
both	NULL
Jurkat-Tax	NULL
and	NULL
various	NULL
HTLV-T-infected	NULL
T-cell	NULL
lines	NULL
expressing	NULL
the	NULL
viral	NULL
Tax	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
strongly	NULL
suggests	NULL
that	NULL
activation	NULL
of	NULL
NF-AT	NULL
may	NULL
be	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
1428	NULL
part	NULL
of	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
HTLV-I	NULL
activates	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
seen	NULL
with	NULL
immunological	NULL
stimuli	NULL
(	NULL
82	NULL
,	NULL
34	NULL
,	NULL
36	NULL
)	NULL
,	NULL
activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
the	NULL
HTLV-|-infected	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
dephosphorylation	NULL
of	NULL
this	NULL
normally	NULL
heavily	NULL
phosphorylated	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
dephosphorylated	NULL
form	NULL
of	NULL
NF-AT1	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
these	NULL
virally	NULL
infected	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
transient	NULL
activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
antigen-stimulated	NULL
noninfected	NULL
T	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

This	NULL
apparent	NULL
deregulation	NULL
of	NULL
NF-AT1	NULL
can	NULL
be	NULL
due	NULL
to	NULL
either	NULL
the	NULL
up-regulation	NULL
of	NULL
calcineurin	NULL
activity	NULL
or	NULL
down-regu-lation	NULL
of	NULL
the	NULL
opposing	NULL
NF-AT	NULL
kinase	NULL
activity	NULL
.	NULL

We	NULL
think	NULL
the	NULL
former	NULL
possibility	NULL
is	NULL
more	NULL
likely	NULL
true	NULL
since	NULL
the	NULL
dephosphorylated	NULL
NF-AT1	NULL
can	NULL
be	NULL
rapidly	NULL
rephosphorylated	NULL
when	NULL
the	NULL
cells	NULL
are	NULL
incubated	NULL
with	NULL
the	NULL
calcineurin	NULL
inhibitor	NULL
CSA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
the	NULL
NF-AT	NULL
kinase	NULL
is	NULL
still	NULL
active	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
rephosphorylated	NULL
NF-AT1	NULL
in	NULL
CSA-treated	NULL
cells	NULL
is	NULL
largely	NULL
retained	NULL
in	NULL
the	NULL
nucleus	NULL
even	NULL
though	NULL
it	NULL
becomes	NULL
inactive	NULL
in	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
underlying	NULL
mechanism	NULL
remains	NULL
to	NULL
be	NULL
further	NULL
investigated	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
nuclear	NULL
form	NULL
of	NULL
NF-AT1	NULL
seen	NULL
in	NULL
the	NULL
CSA-treated	NULL
HTLV-I-transformed	NULL
cells	NULL
is	NULL
not	NULL
fully	NULL
rephosphorylated	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
notion	NULL
,	NULL
the	NULL
nuclear	NULL
form	NULL
of	NULL
NF-AT1	NULL
appears	NULL
to	NULL
migrate	NULL
slightly	NULL
faster	NULL
than	NULL
the	NULL
cytoplasmic	NULL
form	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Studies	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
directly	NULL
analyze	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
the	NULL
two	NULL
different	NULL
forms	NULL
of	NULL
NF-ATL	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Warner	NULL
Greene	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
antisera	NULL
,	NULL
Dr.	NULL
Anjana	NULL
Rao	NULL
for	NULL
the	NULL
NF-AT1	NULL
antibody	NULL
,	NULL
and	NULL
Sandoz	NULL
Pharmaceuticals	NULL
Co.	NULL
for	NULL
the	NULL
CSA	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
Ruscetti	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Gazdar	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Bunn	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Minna	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1980	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

77	NULL
,	NULL
7415-7419	NULL
2	NULL
.	NULL

Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
Nagata	NULL
,	NULL
K.	NULL
,	NULL
Hanaoka	NULL
,	NULL
M.	NULL
,	NULL
Nakai	NULL
,	NULL
M.	NULL
,	NULL
Matsumoto	NULL
,	NULL
T.	NULL
,	NULL
Kinoshita	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Shirakawa	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Miyoshi	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

78	NULL
,	NULL
6476-6480	NULL
3	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

79	NULL
,	NULL
2031-2035	NULL
4	NULL
.	NULL

Kalyanaraman	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
Sarngadharan	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Nakao	NULL
,	NULL
Y.	NULL
,	NULL
Ito	NULL
,	NULL
Y.	NULL
,	NULL
Aoko	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

79	NULL
,	NULL
1653-1657	NULL
5	NULL
.	NULL

Franchini	NULL
,	NULL
G.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

81	NULL
,	NULL
6207-6211	NULL
6	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87	NULL
,	NULL
761-766	NULL
7	NULL
.	NULL

Green	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
and	NULL
Chen	NULL
,	NULL
I.	NULL
S.	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

4	NULL
,	NULL
169-175	NULL
8	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
10	NULL
,	NULL
272-278	NULL
9	NULL
.	NULL

Li	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Siekevitz	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6490-6500	NULL
10	NULL
.	NULL

Curtiss	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
Smilde	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
McGuire	NULL
,	NULL
K.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
.	NULL

16	NULL
,	NULL
3567-3575	NULL
11	NULL
.	NULL

Good	NULL
,	NULL
L.	NULL
,	NULL
Maggirwar	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
Sun	NULL
,	NULL
S.-C.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
3744-3750	NULL
12	NULL
.	NULL

Himes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Katsikeros	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

70	NULL
,	NULL
4001-4008	NULL
13	NULL
.	NULL

Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Geerts	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Aarden	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
14179-14182	NULL
14	NULL
.	NULL

Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Tan	NULL
,	NULL
T.-H.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
1696-1700	NULL
15	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Sun	NULL
,	NULL
Y.-L.	NULL
,	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
Hoey	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
6299-6310	NULL
16	NULL
17	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

Activation	NULL
of	NULL
NF-AT1	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
Cells	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Molecular	NULL
Aspects	NULL
of	NULL
Cellular	NULL
Regulation	NULL
,	NULL
Hormonal	NULL
Control	NULL
Regulation	NULL
of	NULL
Gene	NULL
Transcription	NULL
(	NULL
Cohen	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Foulkes	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

409-432	NULL
,	NULL
Elsevier/North-Holland	NULL
Biomedical	NULL
Press	NULL
,	NULL
Amsterdam	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Brown	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10	NULL
,	NULL
405-455	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
841-843	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
19938	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2064-2070	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
529-532	NULL
.	NULL

Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
Stevenon	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Schwarz	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Antwerp	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
and	NULL
Miyamoto	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
2723-2785	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
,	NULL
649-683	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Clipstone	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

68	NULL
,	NULL
1054-1083	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
274-281	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Loh	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
388-342	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
750-754	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
269	NULL
,	NULL
497-502	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Sun	NULL
,	NULL
Y.-L.	NULL
,	NULL
Williamson	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Xu	NULL
,	NULL
X	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
461-472	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Naito	NULL
,	NULL
Y.	NULL
,	NULL
Tokumitsu	NULL
,	NULL
H.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Saito	NULL
,	NULL
F.	NULL
,	NULL
Hannum	NULL
,	NULL
C.	NULL
,	NULL
Arai	NULL
,	NULL
K.-L.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
2697-2706	NULL
Ho	NULL
,	NULL
S.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Li	NULL
,	NULL
X.	NULL
,	NULL
Franke	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
19898-19907	NULL
Ruff	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
and	NULL
Leach	NULL
,	NULL
K.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
22602-22607	NULL
Park	NULL
,	NULL
J.	NULL
,	NULL
Yaseen	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Sharma	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
20653-20659	NULL
Loh	NULL
,	NULL
C.	NULL
,	NULL
Carew	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Kim	NULL
,	NULL
J.	NULL
,	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
3945-8954	NULL
Shibasaki	NULL
,	NULL
F.	NULL
,	NULL
Price	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Milan	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Mckeon	NULL
,	NULL
F.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
382	NULL
,	NULL
370-373	NULL
Shaw	NULL
,	NULL
K	NULL
.	NULL

T.-Y	NULL
.	NULL

,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Raghavan	NULL
,	NULL
A.	NULL
,	NULL
Kim	NULL
,	NULL
J.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Park	NULL
,	NULL
J.	NULL
,	NULL
Sharma	NULL
,	NULL
S.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Naf	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
11205-11209	NULL
Wesselborg	NULL
,	NULL
S.	NULL
,	NULL
Fruman	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Sagoo	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Bierer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
Burakoff	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
1274-1277	NULL
Loh	NULL
,	NULL
C.	NULL
,	NULL
Shaw	NULL
,	NULL
K	NULL
.	NULL

T.-Y	NULL
.	NULL

,	NULL
Carew	NULL
,	NULL
J.	NULL
,	NULL
Viola	NULL
,	NULL
J.	NULL
P.	NULL
B.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Perrino	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
10884-10891	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
865	NULL
,	NULL
852-855	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Perrino	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Soderling	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
19983	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
8747-8752	NULL
Park	NULL
,	NULL
J.	NULL
,	NULL
Yaseen	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Sharma	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
20653-20659	NULL
Wano	NULL
,	NULL
Y.	NULL
,	NULL
Feinberg	NULL
,	NULL
M.	NULL
,	NULL
Hosking	NULL
,	NULL
J.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
9733-9787	NULL
Salahuddin	NULL
,	NULL
S.	NULL
Z.	NULL
,	NULL
Markham	NULL
,	NULL
P.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
Franchini	NULL
,	NULL
G.	NULL
1.	NULL
,	NULL
Kalyanaraman	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
Virology	NULL
129	NULL
,	NULL
51-64	NULL
Gazdar	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Carney	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
Bunn	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Russell	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
and	NULL
Jaffe	NULL
,	NULL
G.	NULL
P.	NULL
(	NULL
1980	NULL
)	NULL
Blood	NULL
55	NULL
,	NULL
409-417	NULL
Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
Kubonishi	NULL
,	NULL
L.	NULL
,	NULL
Yoshimoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Shiraishi	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Gann	NULL
72	NULL
,	NULL
978-981	NULL
Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
Kubonishi	NULL
,	NULL
I.	NULL
,	NULL
Yoshimoto	NULL
,	NULL
S.	NULL
,	NULL
Akagi	NULL
,	NULL
T.	NULL
,	NULL
Ohtsuki	NULL
,	NULL
Y.	NULL
,	NULL
Shiraishi	NULL
,	NULL
Y.	NULL
,	NULL
Nagata	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Nature	NULL
294	NULL
,	NULL
770-771	NULL
Good	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Sun	NULL
,	NULL
S.-C.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

70	NULL
,	NULL
2730-2735	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Hoffman	NULL
,	NULL
J.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
83-92	NULL
McKinsey	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Scherer	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Al-Murrani	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Green	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
and	NULL
Ballard	NULL
,	NULL
W.	NULL
B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
2083-2090	NULL
Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
Elwood	NULL
,	NULL
J.	NULL
,	NULL
Béraud	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
7377-7384	NULL
McGuire	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Curtiss	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
Larson	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

67	NULL
,	NULL
1590-1599	NULL
Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Irving	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
318-316	NULL
Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1875-1885	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Constitutive	NULL
Dephosphorylation	NULL
and	NULL
Activation	NULL
of	NULL
a	NULL
Member	NULL
of	NULL
the	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
,	NULL
NF-AT1	NULL
,	NULL
in	NULL
Tax-expressing	NULL
and	NULL
Type	NULL
I	NULL
Human	NULL
T-cell	NULL
Leukemia	NULL
Virus-infected	NULL
Human	NULL
T	NULL
Cells	NULL
LiFeng	NULL
Good	NULL
,	NULL
Sanjay	NULL
B.	NULL
Maggirwar	NULL
,	NULL
Edward	NULL
W.	NULL
Harhaj	NULL
and	NULL
Shao-Cong	NULL
Sun	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:1425-1428.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.3.1425	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/3/1425	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
52	NULL
references	NULL
,	NULL
31	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
425	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

